Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
1. Explore the efficacy of Ulinastatin use in improving post-operative pulmonary
insufficiency and safety in pediatric patients undergoing scheduled CPB open heart
surgery to treat Complex Congenital Heart Disease
2. Explore the efficacy of Ulinastatin use in improving intraoperative hemodynamic
instability as well as other post-operative organ recuperation and its impact on
hospital stay & cost
Phase:
Phase 4
Details
Lead Sponsor:
Techpool Bio-Pharma Co., Ltd.
Collaborators:
Children's Hospital of Fudan University Guangzhou General Hospital of Guangzhou Military Command Guangzhou Women and Children's Medical Center Nanjing Children's Hospital Shanghai Children's Medical Center